The pharmacotherapy of schizophrenia is currently dominated by atypical antipsychotics that primarily target dopaminergic signalling, the dysregulation of which has long been considered to have a ...
Drugs such as Cobenfy could reshape the antipsychotic market, providing a more nuanced range of patient options.
Background: Many neuromuscular blockers act as negative allosteric modulators of muscarinic acetylcholine receptors by decreasing affinity and potency of acetylcholine. The neuromuscular blocker ...
Acetylcholine is a neurotransmitter that plays a crucial role in cognitive function, memory retention, and muscle control. Whether you’re looking to enhance your mental clarity, focus ...
In particular, the finding that acetylcholine-receptor antagonists have an antiproliferative effect on neural stem cells has important implications for the understanding and treatment of Alzheimer ...
A drug that has recently been approved for the treatment of schizophrenia could one day be prescribed to Alzheimer’s patients ...
This process of informed clinical observation followed by scientific confirmation is now excitingly poised to usher in a new generation of treatments for schizophrenia and psychosis based on targeting ...